Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epinastine vs azelastine eye drops in seasonal allergic conjunctivitis
CTR20230134Phase 3Completed
- Sponsor
- Zhaoke Ophthalmology
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of epinastine in seasonal allergic conjunctivitis (SAC), sponsored by Zhaoke Ophthalmology. Started Feb 2023; status: completed.
02
Drugs
epinastine
03
Conditions
seasonal allergic conjunctivitis (SAC)
Beyond the preview
Go deeper on CTR20230134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230134.